Oruka Therapeutics (ORKA) Net Cash Flow (2010 - 2026)
Oruka Therapeutics' quarterly Net Cash Flow came in at $2.6 million in Q1 2026, down 88.25% year-on-year from $22.0 million in Q1 2025, and up 105.83% quarter-over-quarter from -$44.3 million in Q4 2025.
Oruka Therapeutics has reported Net Cash Flow for 17 years, with the latest figure at $2.6 million in Q1 2026.
- For the quarter ending Q1 2026, Net Cash Flow fell 88.25% year-over-year to $2.6 million; the trailing twelve-month figure through Mar 2026 stood at -$34.2 million (down 161.19% YoY), and the FY2025 full-year result was -$14.6 million, down 123.78% from the prior year.
- Net Cash Flow for Q1 2026 stood at $2.6 million, up from -$44.3 million in the prior quarter.
- The five-year high for Net Cash Flow was $395.8 million in Q3 2024, with the low at -$349.3 million in Q4 2024.
- Average Net Cash Flow over 5 years is $2.0 million, with a median of -$1.6 million recorded in 2023.
- Peak annual rise in Net Cash Flow reached 23812.04% in 2024, while the deepest fall reached 32977.65% in 2024.
- Tracing ORKA's Net Cash Flow over 5 years: stood at -$1.5 million in 2022, then advanced by 29.32% to -$1.1 million in 2023, then slumped by 32977.65% to -$349.3 million in 2024, then soared by 87.31% to -$44.3 million in 2025, then soared by 105.83% to $2.6 million in 2026.
- The last three Net Cash Flow figures came in at $2.6 million (Q1 2026), -$44.3 million (Q4 2025), and $25.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 625.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 457.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -152.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 60.68 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | 2.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.59 Mn |
| Mar 31, 2026 | 2.59 Mn |
| Dec 31, 2025 | -44.33 Mn |
| Dec 31, 2025 | -44.33 Mn |
| Sep 30, 2025 | 25.86 Mn |
| Sep 30, 2025 | 25.86 Mn |
| Jun 30, 2025 | -18.27 Mn |
| Jun 30, 2025 | -18.27 Mn |
| Mar 31, 2025 | 22.00 Mn |
| Mar 31, 2025 | 22.00 Mn |
| Dec 31, 2024 | -349.30 Mn |
| Dec 31, 2024 | -349.30 Mn |
| Sep 30, 2024 | 395.75 Mn |
| Sep 30, 2024 | 395.75 Mn |
| Jun 30, 2024 | -12.62 Mn |
| Jun 30, 2024 | -12.62 Mn |
| Mar 31, 2024 | 27.74 Mn |
| Mar 31, 2024 | 27.74 Mn |
| Dec 31, 2023 | -1.06 Mn |
| Dec 31, 2023 | -1.06 Mn |
| Sep 30, 2023 | -1.67 Mn |
| Sep 30, 2023 | -1.67 Mn |
| Jun 30, 2023 | -694,000.00 |
| Jun 30, 2023 | -694,000.00 |
| Mar 31, 2023 | -1.60 Mn |
| Mar 31, 2023 | -1.60 Mn |
| Dec 31, 2022 | -1.49 Mn |
| Dec 31, 2022 | -1.49 Mn |
| Sep 30, 2022 | -2.50 Mn |
| Sep 30, 2022 | -2.50 Mn |
| Jun 30, 2022 | -2.62 Mn |
| Jun 30, 2022 | -2.62 Mn |
| Mar 31, 2022 | -4.30 Mn |
| Mar 31, 2022 | -4.30 Mn |
| Dec 31, 2021 | -4.95 Mn |
| Dec 31, 2021 | -4.95 Mn |
| Sep 30, 2021 | -4.88 Mn |
| Sep 30, 2021 | -4.88 Mn |
| Jun 30, 2021 | -3.74 Mn |
| Jun 30, 2021 | -3.74 Mn |
| Mar 31, 2021 | 17.86 Mn |
| Mar 31, 2021 | 17.86 Mn |
| Dec 31, 2020 | -2.02 Mn |
| Dec 31, 2020 | -2.02 Mn |
| Sep 30, 2020 | 40.05 Mn |
| Sep 30, 2020 | 40.05 Mn |
| Jun 30, 2020 | -1.05 Mn |
| Jun 30, 2020 | -1.05 Mn |
| Mar 31, 2020 | -1.69 Mn |
| Mar 31, 2020 | -1.69 Mn |
| Dec 31, 2019 | -1.28 Mn |
| Dec 31, 2019 | -1.28 Mn |
| Sep 30, 2019 | -319,000.00 |
| Sep 30, 2019 | -319,000.00 |
| Jun 30, 2019 | 1.96 Mn |
| Jun 30, 2019 | 1.96 Mn |
| Mar 31, 2019 | 1.40 Mn |
| Mar 31, 2019 | 1.40 Mn |
| Dec 31, 2018 | -1.45 Mn |
| Dec 31, 2018 | -1.45 Mn |
| Sep 30, 2018 | -1.58 Mn |
| Sep 30, 2018 | -1.58 Mn |
| Jun 30, 2018 | -2.46 Mn |
| Jun 30, 2018 | -2.46 Mn |
| Mar 31, 2018 | 3.39 Mn |
| Mar 31, 2018 | 3.39 Mn |
| Dec 31, 2017 | 560,000.00 |
| Dec 31, 2017 | 560,000.00 |
| Sep 30, 2017 | -959,000.00 |
| Sep 30, 2017 | -959,000.00 |
| Jun 30, 2017 | 2.93 Mn |
| Jun 30, 2017 | 2.93 Mn |
| Mar 31, 2017 | -1.23 Mn |
| Mar 31, 2017 | -1.23 Mn |
| Dec 31, 2016 | -694,000.00 |
| Dec 31, 2016 | -694,000.00 |
| Sep 30, 2016 | -6.28 Mn |
| Sep 30, 2016 | -6.28 Mn |
| Jun 30, 2016 | -15.34 Mn |
| Jun 30, 2016 | -15.34 Mn |
| Mar 31, 2016 | -9.09 Mn |
| Mar 31, 2016 | -9.09 Mn |
| Dec 31, 2015 | -2.68 Mn |
| Dec 31, 2015 | -2.68 Mn |
| Sep 30, 2015 | -2.60 Mn |
| Sep 30, 2015 | -2.60 Mn |
| Jun 30, 2015 | 31.90 Mn |
| Jun 30, 2015 | 31.90 Mn |
| Mar 31, 2015 | -3.17 Mn |
| Mar 31, 2015 | -3.17 Mn |
| Dec 31, 2014 | -1.90 Mn |
| Dec 31, 2014 | -1.90 Mn |
| Sep 30, 2014 | -2.13 Mn |
| Sep 30, 2014 | -2.13 Mn |
| Jun 30, 2014 | -1.82 Mn |
| Jun 30, 2014 | -1.82 Mn |
| Mar 31, 2014 | 4.45 Mn |
| Mar 31, 2014 | 4.45 Mn |
| Dec 31, 2013 | -1.88 Mn |
| Dec 31, 2013 | -1.88 Mn |
| Sep 30, 2013 | -1.74 Mn |
| Sep 30, 2013 | -1.74 Mn |
| Jun 30, 2013 | 16.84 Mn |
| Jun 30, 2013 | 16.84 Mn |
| Mar 31, 2013 | 617,000.00 |
| Mar 31, 2013 | 617,000.00 |
| Dec 31, 2012 | -162,000.00 |
| Dec 31, 2012 | -162,000.00 |
| Sep 30, 2012 | -101,000.00 |
| Sep 30, 2012 | -101,000.00 |
| Jun 30, 2012 | -1.04 Mn |
| Jun 30, 2012 | -1.04 Mn |
| Mar 31, 2012 | -1.72 Mn |
| Mar 31, 2012 | -1.72 Mn |
| Dec 31, 2011 | 195,000.00 |
| Dec 31, 2011 | 195,000.00 |
| Sep 30, 2011 | -1.72 Mn |
| Sep 30, 2011 | -1.72 Mn |
| Jun 30, 2011 | -2.11 Mn |
| Jun 30, 2011 | -2.11 Mn |
| Mar 31, 2011 | -1.94 Mn |
| Mar 31, 2011 | -1.94 Mn |
| Dec 31, 2010 | -881,000.00 |
| Dec 31, 2010 | -881,000.00 |
| Sep 30, 2010 | -2.01 Mn |
| Sep 30, 2010 | -2.01 Mn |